The Anti-cancer targets play crucial role in signalling processes of cells. We have developed an Anti-Cancer Scanner (ACS) tool for identification of Anti-cancer targets in form of peptides.
INTRODUCTION
Cancer is one of the most devastating diseases responsible for millions of mortalities worldwide.
Different types of cancers are abundant in different countries, but lungs cancer was reported most commonly cause of death in men while breast cancer was recorded in women. However, stomach, colorectal, liver and prostate cancers are more common in men. Whereas, cervix, lung, colorectal, stomach and breast cancer are uniformly distributed in women [1] . Different risk factors were reported to associated with cancer but most common cause of this disease is the mutations in functionally significant somatic genes [2] . Due to high rate of morbidity and mortality, diagnosis, treatment and prevention of cancer is the utmost priority in the current area of research [3] . Global efforts revealed different approaches for the treatment of cancer including operational therapy; chemo agents-based treatment, hormonal, radiation and biological therapy. However, these approaches are constrained due to its high financial cost, adverse effects and low therapeutics output [4] . So, this conventional treatment has reduced the success rate of cancer treatment [5] . To tackle this devastating condition, new means of treatment are required.
Recently, anti-cancer therapeutic vaccines have been developed and widely explored [6] [7] [8] [9] [10] .
Anti-cancer vaccines (ACV), that contained short chain of amino acids usually less than 50 amino acids, were found to be exceptionally better than conventional chemotherapeutic agents [11] . Other advantages over conventional drugs includes specificity towards the target, no or less intracellular toxicity, alteration feasibility and high penetration power have made these vaccines as promising agents over the purposed methods. Due to promising output, such small vaccines have revolutionized the pharmaceutical markets and number of vaccine therapeutics have been increased in the marketed [12] . Anti-cancer vaccines (ACV) and Antimicrobial vaccines (AMPs) are of same characteristics displaying similar properties. Like cellular surface negativity of bacteria, cancerous cells also possess negative charge and thus, both ACV and AMPs showed broad spectrum of activities. This negatively charge is of significant interest, making potential interaction with the cell surface and thus, selective toxicity can be achieved. These specificity properties divide these vaccines into two different categories; one that shows toxicity against all types of cells including bacterial, cancerous and normal cells while other depicts activity against only bacterial and cancerous cells [13] [14] [15] .
Despite enormous therapeutic significance of Anti-cancer vaccines, till date, no tool for Anticancer vaccines and Anti-cancer proteins/peptides has been developed to identify the vaccines from wild and mutated cancerous protein sequences that can be used as anti-cancer vaccines.
Large databases are available such as data from Clinical Proteomic Tumor Analysis Consortium (CPTAC) [16] which contains proteomic data from mass spectrometry analysis, and compare expression patterns of proteome and transcript. Also, Cancer Genome Atlas (TCGA) [17] is one of the reservoirs of cancerous datasets that holds RNA-sequence data sets. On the other hand, cancer transcriptomics data is provided by microarray expression analysis. Many different cancer mutations related data such as data from Cancer Genomics Hub [18] , Catalogue of Somatic Mutations in Cancer (COSMIC) [19] , SNP500Cancer [20] , and UCSC Cancer Genomics Browser [21] are available.
Despite the availability of such huge data, no efforts have been made to analyze and retrieve important patterns from this big data that could be clinically significant for the treatment of cancer. Therefore, to support the scientific portfolio developing anti-cancer vaccines; we have developed Anti-Cancer Scanner (ACS) tool which accept the cancer associated proteins data including information from the above sources to analyze and retrieve important evidence from them and predict Anti-cancer vaccine from their target sequence using machine learning approach shown in Figure 1 . This proposed tool identifies vaccines/peptides from targeted cancerous protein which means its personalized vaccines for cancer patients. We believe that ACS will be helpful for both bioinformatics and experimental researchers working in the field of Anti-cancer vaccine based therapeutics.
METHODOLOGY Implementation
Following steps in the methodology were followed in the development of ACS:
Data mining of Anti-cancer targets-Many databases were used for data mining; many cancer databases are a molecular group of precise information scheme that gathers heterogeneous records of Anti-cancer targets. Each layers in neural network has one parallel node and consequently building the stacking.
Data set development of Anti-cancer targets-
Output of each neuron is collective information of neurons multiplied by parallel weights with biased value while input value is transformed into output. 
Normalization of Anti-cancer targets
where T i is actual assessment and Y i is estimated assessment.
RESULTS
ACS tool is very useful and reliable tool for Anti-cancer targets analysis. It generates maximum output using minimum input of Anti-cancer targets; using these application users can determine the Anti-cancer vaccines. ACS tool which accept cancer associated proteins data including data from different cancerous resources; then analyze and retrieve important information from their cancer targets/proteins and predict Anti-cancer vaccine using machine learning approach. This proposed tool identifies vaccines/peptides from targeted cancerous protein which means its personalized vaccines for cancer patients.
It is graphical user interface application (Figure 4) where user can easily import cancer target list with mutation information and ACS will predict optimized anti-cancerous peptides from those 2. Submit the job by clicking on submit button.
3. After queryyou submit your, a set of scores will be calculated, depending on which option you selected. Based on the scores, the vaccine will be ranked.
Peptide Motif Search
This package allowed users to locate and rank 8-mer, 9-mer, or 10-mer peptides that contain peptide binding motifs.
Input Instructions

Choose the gene sequence of interest from list with accession number through menu button.
The selection of ID determines which coefficient table in scoring program will be used on the selected sequence.
2. Choose the length of subsequences, program then extracted the information for submitted input sequence and calculated the scores and ranks.
3. Choose whether to display the submitted input sequence on the output page using button.
Submit the job by using submit button.
Output Page Returned to the User
Following query submission, a set of scores are calculated for all 8-mer, 9-mer, or 10-mer subsequences contained in the input sequence, depending on selected option. Based on the scores, subsequences are ranked. This task supposed to complete within a few seconds. After, a display page then returned with following information; An estimated numerical score for subsequence (upon which the rank in the first column is based) shown in Figure 4 . 
ACS tool advantages and applications
ACS is based on machine learning approch for identification of Anti-cancer targets based on their binding affinity. There is no such type of tool for identifying or classifying Anti-cancer targets. The advantage of ACS is analyses information for Anti-cancer targets which can be further assisted in precision drug discovery, identification of novel drug targets, drug designing for these novel targets shown in Figure 6 .
CONCLUSION
We have proposed machine learning algorithm to identify Anti-cancer targets based on their binding affinity and implemented in artificial neural network. There is no such type of tool for identifying or classifying Anti-cancer targets using artificial neural network. It is graphical user interface application where user can easily import cancer target list with mutation information and ACS will predict optimized anti-cancerous vaccines/peptides from those imported targets using artificial neural network; get retrieves the data for anti-cancer targets dataset and fiddle with defined series of attributes and avoid the infiltration of neurons. ACS tool is advantageous for finding information about Anti-cancer targets which can be further assisted or employed in precision drug discovery, identification of novel drug targets, drug designing for these novel targets with a prediction accuracy of 95%. Black box approach were used for ACS script testing, where scripts are examining the functionality of ACS tool. ACS also inbuilt white box testing, where users opposed the functionality of ACS. 
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